Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

FDA grants raloxifene NDA priority review status

July 24, 1997

Genetic and molecular pathogenesis of IDDM

July 24, 1997

Pierre Fabre prepares compounds for hypercholesterolemia/atherosclerosis

July 24, 1997

Hepatic insulin gene expression for treatment of IDDM

July 23, 1997

Diabetes: an epidemic for the 21st century

July 23, 1997

Troglitazone clinical data presented at IDF 97

July 23, 1997

Problems of insulin supply: insulin turns 75

July 23, 1997

FINFAT multicenter trial results reported at IDF 97

July 23, 1997

Recombinant infertility drug launched in Canada

July 23, 1997

Economics of diabetes discussed at IDF 97

July 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...